25 studies recruiting now13 research sites across CanadaJoin the community
A round of applause for our research site physicians Dr Sam Henein and Dr Michael O’Mahony for their participation in the Amarin REDUCE-IT hypertriglyceridemia study! After more than a decade of development and testing, VAZKEPA becomes the first and only European Commission-approved treatment to reduce cardiovascular risk in high-risk, statin-treated adult patients who have elevated triglycerides and other risk characteristics as studied in REDUCE-IT. Keep up the amazing work guys
Connecting Canadians with clinical research studies conducted by a network of physicians committed to advancing medicine — since 1995.
JoinAStudy.ca provides information about clinical research and does not provide medical advice, diagnosis, or treatment. Only a qualified study doctor can determine your eligibility for a study. Participation is always voluntary.
© 2026 JoinAStudy.ca · A network of Canadian physicians.|Designed by Pixelore.ca
